FDA: Bacitracin for Injection to Be Withdrawn From Market
The FDA has requested that all manufacturers of bacitracin for injection voluntarily withdraw their product from the market.
Pneumonia
Clinical Features Identified for First Patients With 2019 Novel Coronavirus
As of Jan. 2, 2020, 41 patients were admitted with laboratory-confirmed 2019 novel coronavirus (2019-nCoV), all of whom had pneumonia.
Pneumonia Risk in COPD Increases With Lower Eosinophils and Bacterial Infection
Patients with both COPD and chronic bacterial infection who had <100 circulating eosinophils/µL were at high risk of developing pneumonia.
Biomarker-Guided Exclusion of VAP Does Not Reduce Antibiotic Use
Biomarker-guided exclusion of ventilator-associated pneumonia was not associated with a reduction in antibiotic use.
Amikacin Plus Standard of Care Does Not Improve Survival in Gram-Negative Pneumonia
Inhaled amikacin adjunctive to standard-of-care intravenous antibiotic therapy was not associated with improvements in survival in mechanically ventilated patients with Gram-negative pneumonia.
Microbiologic Failure in the Setting of Clinical Cure of Bacterial Pneumonia
Microbiologic treatment failure was found to be independently associated with recurrent pneumonia or death among patients with bacterial pneumonia after clinical cure.
China Reports First Death in Coronavirus Outbreak
The first death in an outbreak of a new type of coronavirus was announced Saturday by officials in the central Chinese city of Wuhan.
New Coronavirus May Be Cause of Viral Pneumonia Outbreak in China
A new type of coronavirus may be responsible for dozens of viral pneumonia illnesses in China.
Assessment of HAP and VAP Diagnosis, Treatment, Prevention Guidelines
Data gathered from a meta-analysis of clinical practice guidelines published in the European Journal of Clinical Microbiology and Infectious Diseases, show that well-designed randomized controlled trials are urgently needed.
Risk Factors of Stenotrophomonas maltophilia Ventilator-Associated Pneumonia
Exposure to carbapenem and carboxypenicillin or ureidopenicillin during the week before onset of ventilator-associated pneumonia and the severity of disease with regard to respiratory and hematologic failures were independent risk factors for the occurrence of Stenotrophomonas maltophilia-related VAP.
-
Loading...
-
Loading...
Next post in Pneumonia
